...
机译:Denosumab中断和相关椎骨骨折发生率:自由分析及其延伸
Laval Univ Quebec City PQ Canada;
Geneva Univ Hosp Geneva Switzerland;
Princess Margaret Hosp Christchurch New Zealand;
Hvidovre Univ Hosp Hvidovre Denmark;
Amgen Inc Thousand Oaks CA 91320 USA;
United Osteoporosis Ctr Gainesville GA USA;
Paris Descartes Univ Paris France;
Amgen Inc Thousand Oaks CA 91320 USA;
Soder Sjukhuset Karolinska Inst Stockholm Sweden;
Ctr Clin &
Basic Res Tallinn Estonia;
Amgen Inc Thousand Oaks CA 91320 USA;
Amgen Inc Thousand Oaks CA 91320 USA;
San Francisco Coordinating Ctr CPMC Res Inst San Francisco CA USA;
机译:Denosumab中断和相关椎骨骨折发生率:自由分析及其延伸
机译:Denosumab停止后的椎骨骨折:随机安慰剂控制自由试验的后HOC分析及其延伸
机译:地诺单抗停药及相关骨折发生率:每6个月进行一次Denosumab骨质疏松症的骨折复位评估分析(免费)
机译:利用光谱和分形分析对磁共振图像中的椎体压缩性骨折进行分类
机译:我的椎骨会破裂吗?骨质疏松队列轴向刚度分析腰椎骨折性能的纵向预测
机译:Denosumab停药和相关骨折发生率:每6个月进行Denosumab骨质疏松症的骨折复位评估分析(免费)
机译:Denosumab和相关骨折发生率的停止:每6个月(自由)试验中骨质疏松症的骨折减少评估分析